|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0003364,
umls-concept:C0005823,
umls-concept:C0011860,
umls-concept:C0013227,
umls-concept:C0013560,
umls-concept:C0020538,
umls-concept:C0022658,
umls-concept:C0030705,
umls-concept:C0039021,
umls-concept:C0288171,
umls-concept:C0332307,
umls-concept:C0439858,
umls-concept:C2587213
|
|
pubmed:issue |
21-22
|
|
pubmed:dateCreated |
2006-6-16
|
|
pubmed:abstractText |
The aim of this health economic modelling study was to investigate the effect of irbesartan combined with conventional antihypertensive medications compared to conventional antihypertensive therapy alone on the progression of nephropathy in patients with hypertension, type 2 diabetes and microalbuminuria in a Swiss setting.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1424-7860
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
136
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
346-52
|
|
pubmed:dateRevised |
2011-2-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16779715-Albuminuria,
pubmed-meshheading:16779715-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:16779715-Antihypertensive Agents,
pubmed-meshheading:16779715-Biphenyl Compounds,
pubmed-meshheading:16779715-Cohort Studies,
pubmed-meshheading:16779715-Cost Savings,
pubmed-meshheading:16779715-Creatinine,
pubmed-meshheading:16779715-Diabetes Mellitus, Type 2,
pubmed-meshheading:16779715-Diabetic Nephropathies,
pubmed-meshheading:16779715-Follow-Up Studies,
pubmed-meshheading:16779715-Humans,
pubmed-meshheading:16779715-Hypertension,
pubmed-meshheading:16779715-Life Expectancy,
pubmed-meshheading:16779715-Markov Chains,
pubmed-meshheading:16779715-Practice Guidelines as Topic,
pubmed-meshheading:16779715-Switzerland,
pubmed-meshheading:16779715-Tetrazoles,
pubmed-meshheading:16779715-Time Factors,
pubmed-meshheading:16779715-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
Health economic implications of irbesartan plus conventional antihypertensive medications versus conventional blood pressure control alone in patients with type 2 diabetes, hypertension, and renal disease in Switzerland.
|
|
pubmed:affiliation |
Center for Outcomes Research (CORE), Binningen/Basel, Switzerland.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|
